Evidence map›Paper›PMID 42809154›Full record

ReviewAntonie van Leeuwenhoek2026

Glucansucrases as versatile biocatalysts: structural insights, synthesis of emerging prebiotic oligosaccharides, and their functional roles in food matrices.

Elif Gülşen Karabacak Aydın, Ahmet Hilmi Çon

Abstract readReview
PubMed Publisher
In one paragraph

Review in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elif Gülşen Karabacak AydınDepartment of Food Engineering, Ondokuz Mayıs University, Samsun, Türkiye. elif.karabacak@omu.edu.tr.ORCID https://orcid.org/0000-0002-3513-0986
Ahmet Hilmi ÇonDepartment of Food Engineering, Ondokuz Mayıs University, Samsun, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucansucrases (GSs), primarily members of the Glycoside Hydrolase family 70 (GH70), have emerged as transformative biocatalysts for the sustainable synthesis of high-value α-glucans and tailored oligosaccharides directly from sucrose. This review systematically explores the structural insights and catalytic mechanisms of these enzymes, emphasizing the molecular determinants of linkage specificity and domain organization. By leveraging advanced enzyme engineering and the strategic application of acceptor reactions, it is now possible to produce tailor-made prebiotic oligosaccharides with diverse glycosidic architectures. The integration of these custom polymers into functional food matrices is discussed not only for their nutritional contribution but also for their profound impact on techno-functional properties, such as rheology, texture, and shelf-life. Furthermore, the physiological significance of these emerging prebiotics is evaluated through the lens of selective microbiota modulation, gut barrier reinforcement, and overall metabolic health. Finally, this review navigates the transition from laboratory-scale synthesis to industrial application, addressing the techno-economic challenges and regulatory frameworks essential for commercialization. By bridging the gap between basic biocatalysis and food engineering, glucansucrases stand as pivotal tools for the development of next-generation, health-promoting functional foods.

Indexed as

GlycosyltransferasesOligosaccharidesPrebioticsBiocatalysisFunctional FoodalternansucraseGlycosyltransferasesOligosaccharidesPrebioticsEnzymatic synthesisFunctional food ingredientsGlucansucraseLactic Acid BacteriaPrebiotic oligosaccharidesTransglucosylation

Identifiers

PMID42809154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.